CIK 0001761918 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Erasca, Inc.
Sign in to watch- Ticker
- ERAS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831217027
- Phone
- (858) 465-6511
- Business address
- 3115 MERRYFIELD ROW, THIRD FLOOR, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 10 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-10 | Lim Jonathan E Chairman & CEO | Purchase | +60,000 | $3.86 | $231K | 20,256,222 |
| 2022-12-21 | Start Valerie Denise Harding Director | Purchase | +10,000 | $4.64 | $46K | 10,000 |
| 2022-12-21 | Bristol James Arthur Director | Purchase | +20,000 | $4.14 | $83K | 20,000 |
| 2022-12-15 | Casdin Alexander W. Director | Purchase | +20,000 | $4.87 | $97K | 443,974 |
| 2022-12-14 | Lim Jonathan E Chairman & CEO | Purchase | +40,000 | $4.99 | $200K | 20,196,222 |
| 2022-12-13 | Chen Bihua Director | Purchase | +307,692 | $6.50 | $2.0M | 10,813,246 |
| 2022-12-13 | Chen Bihua Director | Purchase | +307,692 | $6.50 | $2.0M | 10,813,246 |
| 2022-07-01 | Casdin Alexander W. Director | Other disposition | −750,000 | 0 | ||
| 2022-06-22 | Chen Bihua Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-06-22 | Varney Michael David Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2022-06-22 | Multani Pratik S Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-06-22 | Start Valerie Denise Harding Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-06-22 | Hambleton Julie Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-06-22 | Casdin Alexander W. Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-06-22 | Bristol James Arthur Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-04-25 | LIU JEAN I Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2022-02-01 | Garner Ebun General Counsel & Corp. Sec. | Other acquisition | +990 | $11.60 | $11K | 1,890 |
| 2022-02-01 | Garner Ebun General Counsel & Corp. Sec. | Grant or award · Stock Option (Right to Buy) | +171,110 | 171,110 | ||
| 2022-02-01 | Wei Lin Chief Medical Officer | Other acquisition | +1,562 | $11.60 | $18K | 314,062 |
| 2022-02-01 | Wei Lin Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +272,100 | 272,100 |
Page 6 of 7 · 121 trades